Jpmorgan Chase & CO Nant Health, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.61 $68 - $109	-180 Reduced 79.3%	47 $0
Q2 2022 Aug 11, 2022	SELL	$0.42 - $0.78 $5,223 - $9,700	-12,436 Reduced 98.21%	227 $0
Q1 2022 May 11, 2022	SELL	$0.75 - $1.08 $13,669 - $19,684	-18,226 Reduced 59.0%	12,663 $10,000
Q4 2021 Feb 10, 2022	SELL	$0.94 - $1.85 $164,102 - $322,967	-174,577 Reduced 84.97%	30,889 $33,000
Q3 2021 Nov 12, 2021	BUY	$1.61 - $2.41 $330,800 - $495,173	205,466 New	205,466 $331,000

Ticker NH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 115,550,000
Market Cap $48.5M
Description
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Ev...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.